[Hepatitis B virus infection and glomerulonephritis]

Area of Science:

• Nephrology
• Virology
• Immunology

Context:

• Glomerulonephritis (GN) is a significant kidney disease with diverse etiologies.
• Hepatitis B virus (HBV) infection is a global health concern with potential systemic implications.
• The association between HBV and GN requires further investigation.

Purpose:

• To investigate the prevalence of Hepatitis B virus (HBV) markers in patients with glomerulonephritis (GN).
• To compare HBV marker frequency in GN patients with those suffering from other renal diseases.

Summary:

• Hepatitis B surface antigen (HBsAg) was detected in 21.1% of glomerulonephritis (GN) patients, significantly higher than in patients with other kidney diseases (8.3%).
• Anti-HBs antibodies were found in 20.3% of GN patients, similar to HBsAg prevalence.
• Hepatitis B e-antigen (HBeAg) was present in 3 of 15 chronic GN patients with HBsAg, while anti-HBe was detected in 6 chronic GN patients. HBsAg was also detected in one kidney biopsy from 16 GN patients.

Impact:

• Findings suggest a potential association between Hepatitis B virus (HBV) infection and the pathogenesis of glomerulonephritis (GN).
• Highlights the importance of screening for HBV markers in GN patients for comprehensive disease management.
• May inform future research into the role of viral infections in kidney diseases.